These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3718578)

  • 1. Effects of brotizolam on smooth muscle and other organs.
    Ueno K; Kitagawa H; Kitagawa H; Kohei H; Furukawa T; Kushiku K
    Arzneimittelforschung; 1986 Mar; 36(3A):560-7. PubMed ID: 3718578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of brotizolam and diazepam with some psychotropic drugs on motor performance in mice.
    Böke-Kuhn K; Knappen F
    Arzneimittelforschung; 1986 Mar; 36(3A):606-9. PubMed ID: 3718585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemotional and anticonvulsant activity of brotizolam and its effects on motor performance in animals.
    Böke-Kuhn K; Danneberg P; Kuhn FJ; Lehr E
    Arzneimittelforschung; 1986 Mar; 36(3A):528-31. PubMed ID: 2872899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacology of brotizolam in animals.
    Danneberg P; Bauer R; Böke-Kuhn K; Hoefke W; Kuhn FJ; Lehr E; Walland A
    Arzneimittelforschung; 1986 Mar; 36(3A):540-51. PubMed ID: 3718576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of brotizolam on the sleep-waking cycle of the cat.
    Kuhn FJ
    Arzneimittelforschung; 1986 Mar; 36(3A):522-7. PubMed ID: 3718574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological action of some known and possible metabolites of brotizolam.
    Danneberg P; Böke-Kuhn K; Bechtel WD; Lehr E
    Arzneimittelforschung; 1986 Mar; 36(3A):587-91. PubMed ID: 3013212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical dependence capacity of brotizolam in rhesus monkeys. 2nd communication: primary dependence and barbital substitution.
    Stockhaus K
    Arzneimittelforschung; 1986 Mar; 36(3A):601-5. PubMed ID: 3718584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of flurazepam, brotizolam and alcohol on psychomotor performance.
    Krueger H
    Arzneimittelforschung; 1986 Mar; 36(3A):616-20. PubMed ID: 3718586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of brotizolam, a new thienotriazolodiazepine derivative.
    Ueki S; Watanabe S; Yamamoto T; Shibata S; Shibata K
    Jpn J Pharmacol; 1984 Jul; 35(3):287-99. PubMed ID: 6541265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical studies with the new thienotriazolo-diazepine brotizolam.
    Bechtel WD; Ensinger HA; Mierau J
    Arzneimittelforschung; 1986 Mar; 36(3A):534-40. PubMed ID: 3013211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic safety studies of brotizolam in animals.
    Lehr E; Böke-Kuhn K; Danneberg P
    Arzneimittelforschung; 1986 Mar; 36(3A):532-3. PubMed ID: 3718575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
    Bechtel WD; Mierau J; Richter I; Stiasni M
    Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of brotizolam.
    Hewett C; Ellenberger J; Köllmer H; Kreuzer H; Niggeschulze A; Stötzer H
    Arzneimittelforschung; 1986 Mar; 36(3A):592-6. PubMed ID: 3718582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.